Comparative Efficacy of Antrodia cinnamomea on Liver Function Biomarkers in Mice and Rats: A Network Meta-Analysis
- Author: mycolabadmin
- 5/30/2025
- View Source
Summary
Background
Liver diseases, particularly metabolic dysfunction-associated steatotic liver disease (MASLD), represent a major global health challenge with rising prevalence and potential progression to severe conditions. Antrodia cinnamomea, a medicinal mushroom native to Taiwan, has been used in traditional medicine for treating liver dysfunction. Despite growing interest in its hepatoprotective properties, the comparative efficacy of different bioactive extracts remains unclear.
Objective
This study aimed to systematically evaluate and compare the hepatoprotective efficacy of different bioactive extracts from Antrodia cinnamomea (triterpenoids, polysaccharides, and ubiquinone derivatives) on liver function biomarkers using network meta-analysis of animal experiments. The analysis focused on alanine aminotransferase (ALT), aspartate aminotransferase (AST), malondialdehyde (MDA), and tumor necrosis factor-alpha (TNF-α) levels.
Results
Conclusion
- Published in:Antioxidants (Basel),
- Study Type:Network Meta-analysis,
- Source: PMID: 40563294